Wave Life Sciences Ltd. plans to file with the U.S. FDA for accelerated approval of WVE-N531, an exon skipping ...

Elypta AB’s urine-based test correctly identified 90% of patients whose kidney cancer had returned, according to results from an ongoing study. The company’s metabolism-based liquid biopsy platform, ...

The three-dimensional analysis of cell types and their locations by spatial transcriptomics provides key information of their ...

Eight months after announcing the $18.5 million first tranche of its series A, Augustine Therapeutics has closed the ...

Biomérieux SA recently received U.S. FDA 510(k) clearance for its Vitek Compact Pro, a system for microorganism ...

Losing nearly 60% of its value, Mural Oncology plc backed away from its lead interleukin-2 (IL-2) drug, nemvaleukin alfa, in ...

KIMES 2025 exhibition, more than 35,000 products and prototypes were on display. In the clamor, BioWorld engaged with three ...

Sineugene Therapeutics Co. Ltd. has obtained IND clearance from the FDA for SNUG-01, a first-in-class tripartite motif ...

Dengue virus (DENV) is a member of the flavivirus family causing dengue fever, a mosquito-borne disease that can be ...

It has been previously shown that the nuclear receptor subfamily 4 group A (NR4A) plays an important role in cardiovascular ...

Neuronos Ltd., a subsidiary of Beyond Air Inc.’s, has secured an initial $2 million in equity financing from private ...

Prostaglandins induce the regeneration of muscle in rodents and humans through the prostaglandin E2 receptor EP4 subtype ...